Overcoming obstacles to success when transitioning into a cGMP environment

View our on-demand webinar today

 

When transitioning ATMPs from R&D to current cGMP production you are likely to face several challenges. Many of the common pitfalls can be avoided with thoughtful consideration of your equipment needs. Kris Wronski, Cell Culture Applications Scientist from Thermo Fisher Scientific, will discuss critical considerations for effective lab equipment implementation into a cGMP and cleanroom environment. Including:

  • Understanding the unique cGMP compliance framework and challenges for advanced therapy medicinal products (ATMPs).
  • The impact of lab equipment on contamination prevention and safety of therapy products.
  • The crucial factors to consider for lab equipment when moving into cleanroom production.
  • The importance of correct documentation for cleanroom compatibility and an effective qualification process.
  • The role of equipment design in achieving consistent performance and reproducible results.



 

By selecting this option, you are acknowledging that you have read and understand our Privacy Policy.

 


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.